bivalirudin 250 MG in 50 ML Injection
- RxCUI
- 1997015
- RxNorm name
- bivalirudin 250 MG in 50 ML Injection
- Display name
- bivalirudin 250 MG in 50 ML Injection
- Full name
- bivalirudin 250 MG in 50 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bivalirudin | BIVALIRUDIN | MAIA Pharmaceuticals, Inc. | c727199d-f4cd-4658-8fdf-568590beface | 2024-05-27 | Warnings, Adverse reactions | 1997015 |
| Bivalirudin | BIVALIRUDIN | Par Health USA, LLC | 91cf9d00-29e0-4357-a184-f70026c47edb | 2024-03-01 | Warnings, Adverse reactions | 1997015 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 91cf9d00-29e0-4357-a184-f70026c47edb | bivalirudin 250 MG in 50 ML Injection | PSN | 2 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION, safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20241029 |
| 91cf9d00-29e0-4357-a184-f70026c47edb | bivalirudin 250 MG (as bivalirudin trifluoroacetate 275 MG) per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION, safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20241029 |
| 91cf9d00-29e0-4357-a184-f70026c47edb | 50 ML bivalirudin 5 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION, safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20241029 |
| 91cf9d00-29e0-4357-a184-f70026c47edb | bivalirudin 250 MG per 50 ML Injection | SY | 2 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION, safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20241029 |
| c727199d-f4cd-4658-8fdf-568590beface | bivalirudin 250 MG per 50 ML Injection | SY | 1 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20240527 |
| c727199d-f4cd-4658-8fdf-568590beface | bivalirudin 250 MG (as bivalirudin trifluoroacetate 275 MG) per 50 ML Injection | SY | 1 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20240527 |
| c727199d-f4cd-4658-8fdf-568590beface | 50 ML bivalirudin 5 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20240527 |
| c727199d-f4cd-4658-8fdf-568590beface | bivalirudin 250 MG in 50 ML Injection | PSN | 1 | These highlights do not include all the information needed to use BIVALIRUDIN INJECTION safely and effectively. See full prescribing information for BIVALIRUDIN INJECTION. BIVALIRUDIN injection, for intravenous use Initial U.S. Approval: 2000 | 20240527 |